Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
出版年份 2016 全文链接
标题
Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
作者
关键词
-
出版物
Frontiers in Immunology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2016-06-17
DOI
10.3389/fimmu.2016.00238
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune activation of the host cell induces drug tolerance inMycobacterium tuberculosisboth in vitro and in vivo
- (2016) Yancheng Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials
- (2016) Qiaoling Ruan et al. Emerging Microbes & Infections
- Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
- (2016) Selvakumar Subbian et al. EBioMedicine
- Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis
- (2015) Mariama C. Maiga et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections
- (2015) Alimuddin Zumla et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- WHO's new End TB Strategy
- (2015) Mukund Uplekar et al. LANCET
- Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
- (2015) I. V. Lyadova et al. MEDIATORS OF INFLAMMATION
- The Unrecognized Effects of Phosphodiesterase 4 on Epithelial Cells in Pulmonary Inflammation
- (2015) Franziska M. Konrad et al. PLoS One
- Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
- (2015) Meenal Datta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Etanercept Exacerbates Inflammation and Pathology in a Rabbit Model of Active Pulmonary Tuberculosis
- (2014) Liana Tsenova et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Adjuvant Host-Directed Therapy with Types 3 and 5 but Not Type 4 Phosphodiesterase Inhibitors Shortens the Duration of Tuberculosis Treatment
- (2013) Mamoudou Maiga et al. JOURNAL OF INFECTIOUS DISEASES
- Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages
- (2012) Mi-Sun Koo et al. Cell Communication and Signaling
- Phosphodiesterase-4 Inhibition Combined with Isoniazid Treatment of Rabbits with Pulmonary Tuberculosis Reduces Macrophage Activation and Lung Pathology
- (2011) Selvakumar Subbian et al. AMERICAN JOURNAL OF PATHOLOGY
- Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice
- (2011) Mi-Sun Koo et al. PLoS One
- Phosphodiesterase-4 Inhibition Alters Gene Expression and Improves Isoniazid – Mediated Clearance of Mycobacterium tuberculosis in Rabbit Lungs
- (2011) Selvakumar Subbian et al. PLoS Pathogens
- Letting Sleeping dos Lie: Does Dormancy Play a Role in Tuberculosis?
- (2010) Michael C. Chao et al. Annual Review of Microbiology
- Excess lung function decline in gold miners following pulmonary tuberculosis
- (2010) J. Ross et al. THORAX
- Advances in Immunotherapy for Tuberculosis Treatment
- (2009) Gavin J. Churchyard et al. CLINICS IN CHEST MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now